Mysore/Mysuru: In a major breakthrough that can add as a powerful ammunition to the fight against COVID, a Mysuru-based drug development company has discovered a new drug against human anti-SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). SARS-CoV-2 viral multiplication within the cell mainly depends on RdRp, a key enzyme that is involved in the RNA…